Department of Pharmaceutics, University of Washington, Seattle, Washington (A.B., M.K., B.P.); and Pfizer Worldwide Research Development, Drug Safety Research Development, Cambridge, Massachusetts (Z.R., V.S.V.).
Department of Pharmaceutics, University of Washington, Seattle, Washington (A.B., M.K., B.P.); and Pfizer Worldwide Research Development, Drug Safety Research Development, Cambridge, Massachusetts (Z.R., V.S.V.)
Drug Metab Dispos. 2019 Aug;47(8):802-808. doi: 10.1124/dmd.119.086579. Epub 2019 May 23.
Limited understanding of species differences in kidney transporters is a critical knowledge gap for prediction of drug-induced acute kidney injury, drug interaction, and pharmacokinetics in humans. Here, we report protein abundance data of 19 transporters in the kidney cortex across five species (human, monkey, dog, rat, and mouse). In general, the abundance of all of the 19 membrane transporters was higher in preclinical species compared with human except for multidrug resistance protein 1 (MDR1), organic cation transporter (OCT) 3, and OCTN1. In nonhuman primate, the total abundance of 12 transporters for which absolute data were available was 2.1-fold higher ( = 0.025) relative to human but the percentage of distribution of these transporters was identical in both species. Multidrug resistance-associated protein (MRP) 4, OCTN2, organic anion transporter (OAT) 2, sodium/potassium-transporting ATPase, MRP3, SGLT2, OAT1, MRP1, MDR1, and OCT2 were expressed differently with cross-species variabilities of 8.2-, 7.4-, 6.1-, 5.9-, 5.4-, 5.2-, 4.1-, 3.3-, and 2.8-fold, respectively. Sex differences were only significant in rodents and dog. High protein-protein correlation was observed in OAT1 versus MRP2/MRP4 as well as OCT2 versus MATE1 in human and monkey. The cross-species and sex-dependent protein abundance data are important for animal to human scaling of drug clearance as well as for mechanistic understanding of kidney physiology and derisking of kidney toxicity for new therapeutic candidates in drug development.
对肾脏转运体种间差异的认识有限,是预测药物引起的急性肾损伤、药物相互作用和人体药代动力学的一个关键知识空白。在这里,我们报告了五个物种(人类、猴子、狗、大鼠和小鼠)肾脏皮质中 19 种转运体的蛋白丰度数据。一般来说,除了多药耐药蛋白 1(MDR1)、有机阳离子转运体(OCT)3 和 OCTN1 外,所有 19 种膜转运体在临床前物种中的丰度都高于人类。在非人类灵长类动物中,对于有绝对数据的 12 种转运体,其总丰度相对人类高 2.1 倍(=0.025),但这两种物种中这些转运体的分布比例相同。多药耐药相关蛋白(MRP)4、OCTN2、有机阴离子转运体(OAT)2、钠/钾转运 ATP 酶、MRP3、SGLT2、OAT1、MRP1、MDR1 和 OCT2 的表达不同,跨物种变异性分别为 8.2、7.4、6.1、5.9、5.4、5.2、4.1、3.3 和 2.8 倍。只有在啮齿动物和狗中才观察到性别差异。在人类和猴子中,OAT1 与 MRP2/MRP4 以及 OCT2 与 MATE1 之间观察到高的蛋白-蛋白相关性。种间和性别依赖性的蛋白丰度数据对于从动物到人进行药物清除的比例以及对于理解肾脏生理学和降低新治疗候选药物的肾脏毒性风险具有重要意义。